4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3,4-difluorophenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3,4-difluorophenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3,4-difluorophenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-1346 |
| Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3,4-difluorophenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 476.46 |
| Molecular Formula: | C21 H18 F2 N4 O5 S |
| Smiles: | C1CC(C1)c1nc(CN2C(COc3ccc(cc23)S(Nc2ccc(c(c2)F)F)(=O)=O)=O)no1 |
| Stereo: | ACHIRAL |
| logP: | 3.2241 |
| logD: | 1.7739 |
| logSw: | -3.647 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 97.909 |
| InChI Key: | RGWZFEWYDPYLAG-UHFFFAOYSA-N |